NantHealth (NASDAQ:NH) Earns Hold Rating from Analysts at StockNews.com

Posted by on Dec 14th, 2024

Equities researchers at StockNews.com assumed coverage on shares of NantHealth (NASDAQ:NH – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the stock.

NantHealth Price Performance

NantHealth has a 12 month low of $1.24 and a 12 month high of $9.75. The stock has a market cap of $1.93 million, a PE ratio of -0.03 and a beta of 1.82. The business has a fifty day moving average of $0.07 and a 200-day moving average of $0.21.

About NantHealth

(Get Free Report)

NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.

Featured Stories

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.